HIQA’s Strategic Blueprint for Health Care Excellence: Draft Corporate Plan 2025-2027

By João L. Carapinha

October 28, 2024

The HIQA Draft Corporate Plan 2025-2027 outlines the strategic direction and objectives of the Health Information and Quality Authority (HIQA) for the next three years. It serves as a roadmap for HIQA, emphasizing its commitment to promoting high standards in health and social care services across Ireland. Here are the key points from the document:

Foreword and Introduction

This plan marks HIQA’s 20th anniversary and reflects on its journey of continuous improvement, innovation, and collaboration in enhancing health and social care.

Strategic Direction

The HIQA Draft Corporate Plan 2025-2027 is designed to achieve tangible outcomes by 2027. It focuses on evidence-informed decision-making, standard setting, and regulation to ensure the best possible outcomes for health and social care.

Objectives and Priorities

HIQA aims to ensure that health and social care providers consistently deliver excellent standards of care and the best possible outcomes for service users. Key priorities include:
– Promoting safety and quality in health and social care services.
– Enhancing the health and welfare of the public by ensuring care is safe, effective, and respectful of individual rights.
– Responding to emerging challenges and opportunities in the health and social care landscape.

Stakeholder Engagement

HIQA developed the Draft Corporate Plan 2025-2027 through an extensive engagement programme with stakeholders, including patients, service users, policymakers, service providers, advocacy groups, HIQA staff, and the wider public.

Implementation and Monitoring

HIQA‘s Board and Executive Management Team will closely monitor and review the implementation of the Corporate Plan. A performance delivery agreement is in place between HIQA and the Department of Health to ensure alignment with Government priorities and external challenges.

Key Assumptions

The expansion of HIQA’s remit will occur on a gradual basis with sufficient time and additional resources.
– Extra resources will be allocated to support unplanned activities.
– Exchequer funding will adjust in accordance with changes to public sector pay scales and overall operating costs.

Human Rights and Sustainability

HIQA is dedicated to promoting human rights and valuing the needs of the communities it serves. The plan integrates sustainability and the UN Sustainable Development Goals into all relevant activities.

Long-term Outcomes

The plan establishes desired outcomes over the next three years while considering longer-term impacts, providing benchmarks for measuring success. Key outcomes include advancing HIQA’s vision and mission through improved health and social care standards and results.

Overall, the HIQA Draft Corporate Plan 2025-2027 is a comprehensive document that outlines a clear strategic direction, prioritizes stakeholder engagement, and emphasizes the importance of quality, safety, and sustainability in health and social care services.

Reference url

Recent Posts

transparency in industry partnerships
   

Transparency in Industry Partnerships: Building Trust

🔍 How does transparency in industry partnerships impact patient care?

In the evolving landscape of healthcare, EFPIA’s mandatory disclosure requirements for financial interactions underscore the vital role of transparency in fostering trust and collaboration. By detailing financial transfers to healthcare professionals and organizations, the European Disclosure Gateway facilitates informed decision-making and strengthens relationships between stakeholders.

Have a look at the article to explore how these initiatives not only enhance public confidence but also drive innovation in treatments!

#SyenzaNews #HealthcareInnovation #HealthEconomics #innovation

DALY modeling methods
        

DALY Modeling Methods for Enhanced Health Economics and Policy Analysis

How can DALY modeling methods revolutionize health policy and decision analysis? 🔍

DALY modeling techniques provide vital insights into disease burden, helping policymakers and analysts make informed, evidence-based decisions about resource allocation. This article breaks down the latest advancements in DALY modeling, ensuring you grasp the methodologies that can enhance health economics practices.

Don’t miss out on learning how these robust methods can shape better health outcomes. Dive into the full article for all the essential details!

#SyenzaNews #HealthEconomics #HealthcarePolicy

pharmaceutical pricing issues
      

Pharmaceutical Pricing Issues: Beyond Overpricing and Profit Motives

💊 Are high drug prices justified by R&D investments, or is there more to the story?

In a thought-provoking critique, a recent BMJ article argues that profit motives are driving pharmaceutical pricing issues while highlighting the tough decisions regarding access to Alzheimer’s drugs in the UK. It raises vital concerns about the implications for lower-income countries and emphasizes the need for a balanced discussion on drug pricing and innovation.

Curious about the complexities of pharmaceutical pricing and how they shape global health access? Dive into the full article for a nuanced exploration!

#SyenzaNews #pharmaceuticals #HealthEconomics #healthcarepolicy

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.